Kuros Biosciences AG (LON:0RHR)
London · Delayed Price · Currency is GBP · Price in CHF 30.13
+1.07 (3.67%)
At close: Oct 31, 2025
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.11 billion as of November 3, 2025. Its market cap has increased by 45.00% in one year.
Market Cap
1.11B
Enterprise Value
1.09B
Revenue
94.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.13
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 2.27B to 1.11B, a decrease of -51.14%. That is a compound annual growth rate of -7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 1.11B | 55.98% |
| Dec 30, 2024 | 709.81M | 493.45% |
| Dec 29, 2023 | 119.61M | 148.06% |
| Dec 30, 2022 | 48.22M | -5.76% |
| Dec 30, 2021 | 51.17M | -7.21% |
| Dec 30, 2020 | 55.14M | 27.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.55B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.65B |